Skip to content

Sanofi India Limited Price, Chart & Factor Analysis

Free Data & Analytics Access
Sanofi India Limited · E.SANOFI.NSE · India
Use symbol E.SANOFI.NSE in our API & Excel add-in to retrieve this data ↓
3,349.80
(+0.05%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 50%
Bubble Risk LOW
Realised Volatility (20D) 45.29%

Sanofi India Limited Forecast

Sanofi India Limited short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is positive (6 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 45.3% a year, a typical one-standard-deviation range is 3,136–3,563 over a week, 2,912–3,788 over a month and 1,833–4,867 over a year. (Signals as of 5 Nov 2026.)

Sanofi India Limited Price Chart

MacroFinance.ai

Sanofi India Limited Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Sanofi India Limited
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Sanofi India Limited
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Sanofi India Limited
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Sanofi India Limited, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Sanofi India Limited

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Sanofi India Limited Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Sanofi India Limited; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

About Sanofi India Limited

Sanofi India Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Sanofi India Limited

Frequently asked questions

What is Sanofi India Limited?
Sanofi India Limited is a listed security in India. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the trading strategies that hold it and free historical data.
What is the latest Sanofi India Limited price?
The latest close is 3,350 (5 Nov 2026), +0.05% on the day. The price at the top of the page refreshes during the trading day.
Is Sanofi India Limited in an uptrend?
As of 5 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (6 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Sanofi India Limited?
20-day realised volatility is 45.3% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 13.1% over a month and 6.4% over a week.
What factors affect Sanofi India Limited?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Sanofi India Limited, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Sanofi India Limited?
28 backtested tactical asset allocation strategies trade Sanofi India Limited through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
Where can I download free Sanofi India Limited historical data?
In the Free historical data section of this page: the last 10 years of Sanofi India Limited daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Sanofi India Limited historical data (last 10 years)

Browse or instantly download the last 10 years of Sanofi India Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.SANOFI.NSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-203206.1
2026-11-193202.5
2026-11-183231.8
2026-11-173223.9
2026-11-163281.9
2026-11-133301.4
2026-11-123280.9
2026-11-113306.8
2026-11-093329.3
2026-11-063283.1
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.